ArticleMolecular cancer therapeutics2026

Targeting Semaphorin 7a signaling in preclinical models of endocrine therapy-resistant breast cancer.

Rachel N Steinmetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.